Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

UCLA Pediatric Cancer Services

Pediatric cancer care at UCLA is facilitated by the Division of Pediatric Hematology/Oncology, with clinical services provided primarily at the Mattel Children's Hospital UCLA. The Pediatric Hematology/Oncology Program is a pioneer in the treatment of childhood cancers and part of the Jonsson Comprehensive Cancer Center, well known for its new and innovative ways of treating patients.

Over a span of more than four decades, the physicians, nurses, social workers, child life specialists, psychologists, pharmacists, research assistants and other team members of the Program have provided state-of-the-art care for families and their children with cancer and blood disorders. With the support of its multidisciplinary team, including Child Life/Child Development Services and social work, the Program's efforts continue to improve significantly the quality of life and quality of care for children with cancer and blood disorders.

Comprehensive and Compassionate Care

The Division of Pediatric Hematology/Oncology at Mattel Children’s Hospital UCLA wholeheartedly believes that each child is precious and should be able to experience the joys of childhood, not forced to confront illness, pain, disability and mortality. Improving patients’ quality of life is what motivates the team to solve the mysteries of pediatric cancers and blood disorders. When disease strikes a child, it impacts their entire family. Our team’s holistic approach to children with cancer or blood disorders and their families takes this into account, providing family-centered care.

Dr. Noah Federman with PatientA leader in the field introducing a number of new pediatric cancer technologies and treatments, UCLA was one of the first institutions in the world to successfully perform an allogeneic bone marrow transplant and has one of the longest continuously running transplant programs in the world. Our dendritic cell-based vaccine trial is the only one like it in the country for children with aggressive brain tumors. The young adult cancer survivorship program is one of the most successful in the country, utilizing a multidisciplinary approach to help young cancer survivors live a rich and fulfilling life.

These programs, and those below, are some of the many in the Pediatric Hematology/Oncology Program that offer hope to children and their families with cancer and blood disorders:

  • Pediatric Blood and Marrow Transplant Center
  • Blood Disorders Center
  • Pediatric Neuro-Oncology and Neural Tumors Center
  • Pediatric Bone and Soft Tissue Sarcoma Center
  • Children's Oncology Group
  • Pediatric Cancer Research Foundation Consortium

Survivorship

Today, nearly 80 percent of all children with cancer have a chance of surviving five years and beyond thanks to remarkable advances in treatments. The dramatic growth in survivorship has created a community that may face unique health and psychological challenges as they age.

Pediatric cancer survivors, as a child or adult, have the unique opportunity to access comprehensive long-term survivorship care through the UCLA-LIVESTRONG™ Survivorship Center of Excellence. As one of only nine centers nationally, it has become the focal point of survivorship activities at UCLA's Jonsson Comprehensive Cancer Center (JCCC) and UCLA Healthcare. The center is developing models of healthcare delivery to meet the physical and psychosocial needs of cancer survivors.

The center’s clinical programs include:

  • Life After Cancer Clinic for Long-Term Follow-Up Care for childhood cancer survivors less than 18 years of age
  • VITA Clinic for adult survivors of childhood cancer

Clinical Trials

Pediatrics LabThe Pediatric Hematology/Oncology Program provides access to cutting-edge new therapies developed here at UCLA and the Jonsson Comprehensive Cancer Center through the collaboration of doctors, oncologists, researchers and clinicians. We are active participants in several national and regional pediatric clinical cooperative groups offering access to these innovative trials.

The Pediatric Hematology/Oncology Program has been a participant in Pediatric Clinical Trials for over 25 years. Greater than ninety percent of all pediatric oncology patients in this program are enrolled on at least one clinical trial. The majority of patients are on at least two trials.

If you are interested in finding out more about these studies, visit our Clinical Trials Guide for general information and a listing of currently open clinical trials.

Additional Resources

For additional information on pediatric cancer care services provided by the Division of Pediatric Hematology/Oncology at UCLA, visit these links:

Last updated: 6/2/2010 10:32:22 AM